ARO BIOTHERAPEUTICS COMPANY

Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins. The company is developing a wholly-owned pipeline of Centyrin-based therapeutic candidates and is working with industry partners to leverage Centyrins for tissue-specific targeting of therapeutics for a diverse set of diseases... Aro is a product-focused platform company, developing a wholly owned proprietary pipeline and a partnered pipeline of Centyrin-RNA drug conjugates to address previously intractable diseases.

Also known as: Aro, Aro Biotherapeutics

Primary location: Philadelphia United States